∆9-THC	(−)-∆9-Trans-Tetrahydrocannabinol
ALS	Amyotrophic Lateral Sclerosis
AO	Spontaneous Osteoarthritis
API	Active Pharmaceutical Ingredient
CBCV	Cannabichromevarin
CBD	Cannabidiol
CBDA	Cannabidiolic Acid
CBD-GA	Glatiramer Acetate And CBD
CBDV	Canabidivarina
CDC	Centers for Disease Control and Prevention
CFA	Freud’s Adjuvant
Cmax	Maximal Concentration
EAE	Autoimmune Encephalitis
EB	Epidermolysis Bullosa
FJB	Fluoro-Jade B
FXS	Fragile X Syndrome
IL-6	Interleukine 6
IOP	Intraocular Pressure
LPXA4	Anti-Inflammatory Lipoxin
MPO	Myeloperoxidase
MS	Multiple Sclerosis
NDS	Nasal Delivery System
NEPE 14	Noneuphoric Phytocannabinoid Elixr 14
NSAID	Non-Steroidal Anti-Inflammatory Drug
PARS-S	Pediatric Anxiety Rating Scale
PedQLI	Pediatric Quality OF Life Inventory
POEM	Patient Oriented Eczema Measure
QOLHEQ	Quality OF Life Hand Eczema Questionnaire
ROS	Reactive Oxygen Species
SPS	Stiff-Person Syndrome
THCA	Tetrahydrocannabinolic Acid
THC-COOH	11-nor-9-carboxy-thc
TNFα	Tumor Necrosis Factor
UVA	Ultraviolet Rays A
UVB	Ultraviolet Rays B